BioCentury | Apr 15, 2013
Clinical News

North American Vaccine regulatory update

...and tetanus but at risk for pertussis, allowing vaccination of older children and young adolescents. North American Vaccine Inc....
BioCentury | May 17, 2010
Regulation

Adventitious Detection

...were 55,000-70,000 hospitalizations due to rotavirus in 2006. Barbara Howe, VP and director of GSK's North American vaccine...
BioCentury | Sep 14, 2009
Regulation

Choosing Cervarix or Gardasil

An FDA panel's recommendation for approval of Cervarix means that GlaxoSmithKline plc 's bivalent HPV vaccine may soon compete with Merck & Co. Inc. 's Gardasil , a quadrivalent HPV vaccine that has been available in...
BioCentury | Sep 1, 2003
Finance

Ebb & Flow

A horse kept in the stable too long can turn a measured trot into a mad sprint. Not one IPO has gotten done yet, but 10 companies are already in the queue, with about $800...
BioCentury | Jan 22, 2002
Clinical News

NeisVac-C group C meningococcal conjugate vaccine regulatory update

...to BAX for its NeisVac-C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine Inc....
BioCentury | Jan 14, 2002
Company News

Canada approves Baxter's NeisVac-C

...its NeisVac-C meningococcal group C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine...
BioCentury | Nov 5, 2001
Company News

Shire Pharmaceuticals Group plc, Baxter sales and marketing update

...and is under review in Canada. BAX acquired the product through its 1999 purchase of North American Vaccine Inc....
BioCentury | Jul 24, 2000
Clinical News

NeisVac-C group C meningococcal conjugate vaccine regulatory update

...NeisVac-C to prevent meningococcal infection in children one year and older. NeisVac-C was developed by North American Vaccine Inc....
BioCentury | Jul 24, 2000
Company News

Antex management update

...diseases Hired: Stephen Keith as president and COO, formerly VP of marketing and sales at North American Vaccine Inc. WIR...
BioCentury | Jul 19, 2000
Company News

Baxter receives approval for NeisVac-C

...meningococcal infection, which causes meningitis, in children one year and older. NeisVac-C was developed by North American Vaccine...
Items per page:
1 - 10 of 123
BioCentury | Apr 15, 2013
Clinical News

North American Vaccine regulatory update

...and tetanus but at risk for pertussis, allowing vaccination of older children and young adolescents. North American Vaccine Inc....
BioCentury | May 17, 2010
Regulation

Adventitious Detection

...were 55,000-70,000 hospitalizations due to rotavirus in 2006. Barbara Howe, VP and director of GSK's North American vaccine...
BioCentury | Sep 14, 2009
Regulation

Choosing Cervarix or Gardasil

An FDA panel's recommendation for approval of Cervarix means that GlaxoSmithKline plc 's bivalent HPV vaccine may soon compete with Merck & Co. Inc. 's Gardasil , a quadrivalent HPV vaccine that has been available in...
BioCentury | Sep 1, 2003
Finance

Ebb & Flow

A horse kept in the stable too long can turn a measured trot into a mad sprint. Not one IPO has gotten done yet, but 10 companies are already in the queue, with about $800...
BioCentury | Jan 22, 2002
Clinical News

NeisVac-C group C meningococcal conjugate vaccine regulatory update

...to BAX for its NeisVac-C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine Inc....
BioCentury | Jan 14, 2002
Company News

Canada approves Baxter's NeisVac-C

...its NeisVac-C meningococcal group C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine...
BioCentury | Nov 5, 2001
Company News

Shire Pharmaceuticals Group plc, Baxter sales and marketing update

...and is under review in Canada. BAX acquired the product through its 1999 purchase of North American Vaccine Inc....
BioCentury | Jul 24, 2000
Clinical News

NeisVac-C group C meningococcal conjugate vaccine regulatory update

...NeisVac-C to prevent meningococcal infection in children one year and older. NeisVac-C was developed by North American Vaccine Inc....
BioCentury | Jul 24, 2000
Company News

Antex management update

...diseases Hired: Stephen Keith as president and COO, formerly VP of marketing and sales at North American Vaccine Inc. WIR...
BioCentury | Jul 19, 2000
Company News

Baxter receives approval for NeisVac-C

...meningococcal infection, which causes meningitis, in children one year and older. NeisVac-C was developed by North American Vaccine...
Items per page:
1 - 10 of 123